Meta-analysis: Risk of hyperhidrosis with second-generation antidepressants.

about

Meta-analysis: Risk of hyperhidrosis with second-generation antidepressants.

Item

http://www.wikidata.org/entity/Q46182025

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Meta-analysis: Risk of hyperhidrosis with second-generation antidepressants.

@en

Meta-analysis: Risk of hyperhidrosis with second-generation antidepressants.

@nl

type

Item

label

Meta-analysis: Risk of hyperhidrosis with second-generation antidepressants.

@en

Meta-analysis: Risk of hyperhidrosis with second-generation antidepressants.

@nl

prefLabel

Meta-analysis: Risk of hyperhidrosis with second-generation antidepressants.

@en

Meta-analysis: Risk of hyperhidrosis with second-generation antidepressants.

@nl

P1476

Meta-analysis: Risk of hyperhidrosis with second-generation antidepressants.

@en

P2093

Chad Beyer

http://www.w3.org/2001/XMLSchema#string

Jessica A Johnson

http://www.w3.org/2001/XMLSchema#string

Kiley Cappetta

http://www.w3.org/2001/XMLSchema#string

P2860

Cyproheptadine for drug-induced sweating

Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.

Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder.

Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials.

Managing depression in medical outpatients.

A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorder.

Drug-induced hyperhidrosis and hypohidrosis: incidence, prevention and management.

A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder.

A randomized, double-blind, placebo-controlled 8-week trial of the efficacy and tolerability of multiple doses of Lu AA21004 in adults with major depressive disorder.

A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder.

P304

1134-1146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1002/DA.22680

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael H Bloch

P577

2017-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28881483

http://www.w3.org/2001/XMLSchema#string